Session Details
[2YIA18a]YIA Pharmacology Group 3
Tue. Mar 18, 2025 1:40 PM - 3:30 PM JST
Tue. Mar 18, 2025 4:40 AM - 6:30 AM UTC
Tue. Mar 18, 2025 4:40 AM - 6:30 AM UTC
Room 18
Oranizers : Masataka Asagiri (Department of Pharmacology, Graduate School of Medicine, Yamaguchi University) and Takahiro Sato (Institute of Life Science, Kurume University)
[2YIA18a-1]Physiological role of immune-brain communication by extracellular vesicles under septic circulation failure
○Tomoka Ao1,2, Ryuki Kunimaru1, Atsushi Kasai4, Hitoshi Hashimoto1,2,5,6,7, Masaru Ishii3 (1.Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences , Osaka Univ., 2.Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, 3.Immunology and Cell Biology, Graduate School of Medicine, Osaka University, 4.Systems Neuropharmacology, Research Institute of Environmental Medicine, Nagoya University,, 5.Division of Bioscience, Institute for Datability Science, Osaka University, 6.Transdimensional Life Imaging Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, 7.Department of Molecular Pharmaceutical Science, Graduate School of Medicine, Osaka University)
[2YIA18a-2]Effects of Prednisolone Administration on Mast Cell Activation
○Hirokatsu Ito1, Haruna Yamada1, Tenga Mizutani1, Shuang Liu2, Masaki Mogi2 (1.Department of Pharmacology, Ehime University School of Medicine, 2.Department of Pharmacology, Ehime University Graduate School of Medicine)
[2YIA18a-3]LPA receptor stimulation promotes the shift of macrophages to an anti-inflammatory phenotype and suppresses the production of pro-inflammatory cytokines.
○Wataru Nagata, Kayoko Kodama, Keiichi Nakagawa, Toshiaki Ishizuka (Department of pharmacology, National Defense Medical College)
[2YIA18a-4]Analyses of relationship between lung fibrosis and steroid resistance in severe asthma
○Hayato Shimora1, Hiroto Maeyama1, Ryunosuke Tanioka1, Yuichiro Kaibori2, Nobuyuki Yamagishi2, Masaya Matsuda1, Takeshi Nabe1 (1.Laboratory of Immunopharmacology, Faculty of Pharmaceutical Sciences, Setsunan University, 2.Laboratory of Analytics for Biomolecules, Faculty of Pharmaceutical Science, Setsunan University)
[2YIA18a-5]NSAIDs administration promotes allergic sensitization by altering the production of lipid mediators
○Toa Okawara1, Akane Hayashi1, Takahisa Murata1,2,3 (1.Animal Radiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 2.Food and Animal Systemics, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 3.Veterinary Pharmacology, Graduate School of Agricultural and Life Sciences, The University of Tokyo)
[2YIA18a-6]Novel Mechanisms of Neurotoxicity by CB1 Receptor Antagonists
○Kazuaki Mori1, Akinobu Togo2, Kota Yamashita3, Taishi Umezawa3, Keisuke Ohta2, Toru Asahi1,4, Chihiro Nozaki5, Kosuke Kataoka4,6 (1.Grad. Sch. Adv. Sci. Eng., Waseda Univ., 2.Adv. Imag. Res. Cent., Kurume Univ. Sch. Med., 3.Grad. Sch. Bio-Appl. Syst. Eng., Tokyo Univ. Agri. Tech., 4.Comp. Res. Org., Waseda Univ., 5.Glob. Cent. Sci. Eng., Waseda Univ., 6.Grad. Sch. Eng., Tokyo Univ. Agri. Tech.)
[2YIA18a-7]Artificial Intelligence-Based Analysis of Oral Flora and Disease Relationships and Visualization of Results
○Junpei Naito1, Manabu Ishida1, Haruki Usuda2, Tomomi Niibayashi2, Koichiro Wada2 (1.ERISA Co., Ltd., 2.Department of Pharmacology, Shimane University Faculty of Medicine)
[2YIA18a-8]Mechanisms regulating the expression level of the lipid-metabolising enzyme ceramide kinase in neuroblastoma.
○shimon nakajima, Miaki Uzu, Tosihiko Murayama, Hiroyuki Nakamura (chiba university)
[2YIA18a-9]Prediction of therapeutic target molecules for rare diseases using gene perturbation transcriptome and semi-supervised deep learning
○Satoko Namba, Li Chen, Otani Noriko, Yamanishi Yoshihiro (Department of Complex Systems Science, Graduate School of Informatics, Nagoya University)